IFN-α/β receptor interactions to biologic outcomes: Understanding the circuitry

Journal of Interferon and Cytokine Research

Volumn 22, Issue 8, 2002, Pages 835-845

  Brierley, Melissa M ^a   Fish, Eleanor N ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; BETA INTERFERON RECEPTOR; CELL SURFACE RECEPTOR; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR; CYTOKINE; INTERFERON RECEPTOR; KAPPA INTERFERON; MITOGEN ACTIVATED PROTEIN KINASE; OMEGA INTERFERON; TAU INTERFERON; UNCLASSIFIED DRUG; ALPHA BETA INTERFERON RECEPTOR; ALPHA INTERFERON; BETA INTERFERON; MEMBRANE PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR;

ANTIVIRAL ACTIVITY; BINDING AFFINITY; CELL SPECIFICITY; CELL SURFACE; CYTOKINE RELEASE; EXTRACELLULAR SPACE; GROWTH INHIBITION; HOMEOSTASIS; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; LITERATURE; MEDIATOR RELEASE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; REVIEW; SIGNAL PROCESSING; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; CELL DIVISION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; CELL DIVISION; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; MEMBRANE PROTEINS; MICE; MODELS, BIOLOGICAL; PROTEIN BIOSYNTHESIS; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VIRUS DISEASES; VIRUS REPLICATION;

EID: 0036690536     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999002760274845     Document Type: Review

References (131)

1. Brassard, D.L., Grace, M.J., and Bordens, R.W. (2002). Interferon-alpha as an immunotherapeutic protein. J. Leukocyte Biol. 71, 565-581.
2. Domanski, P., and Colamonici, O.R. (1996). The type-I interferon receptor. The long and short of it. Cytokine Growth Factor Rev. 7, 143-151.
3. De Maeyer, E., and De Maeyer-Guignard, J. (1998). Type I interferons. Int. Rev. Immunol. 17, 53-73.
4. Stark, G.R., Kerr, I.M., Williams, B.R., Silverman, R.H., and Schreibner, R.D. (1998). How cells respond to interferons. Annu. Rev. Biochem. 67, 227-264.
5. Lafleur, D.W., Nardelli, B., Tsareva, T., Mather, D., Feng, P., Semenuk, M., Taylor, K., Buergin, M., Chinchilla, D., Roshke, V., Chen, G., Ruben, S.M., Pitha, P.M., Coleman, T.A., and Moore, P.A. (2001). Interferon-kappa, a novel type I interferon expressed in human keratinocytes. J. Biol. Chem. 276, 39765-39771.
6. Uze, G., Lutfalla, G., and Gresser, I. (1990). Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. Cell 60, 225-234.
7. Lutfalla, G., Holland, S.J., Cinato, E., Monneron, D., Reboul, J., Rogers, N.C., Smith, J.M., Stark, G.R., Gardiner, K., Mogensen, K.E., et al. (1995). Mutant U5A cells are complemented by an interferon-alpha beta receptor sub-unit generated by alternative processing of a new member of a cytokine receptor gene cluster. EMBO J. 14, 5100-5108.
8. Comanski, P., Witte, M., Kellum, M., Rubinstein, M., Hackett, R., Pitha, P., and Colamonici, O.R. (1995). Cloning and expression of a long form of the beta subunit of the interferon alpha beta receptor that is required for signaling. J. Biol. Chem. 270, 21606-21611.
9. Colamonici, O.R., Uyttendaele, H., Domanski, P., Yan, H., and Krolewski, J.J. (1994). p135tyk2, an interferon-alpha-activated tyrosine kinase, is physically associated with an interferon-alpha receptor. J. Biol. Chem. 269, 3518-3522.
10. Colamonici, O., Yan, H., Domanski, P., Handa, R., Smalley, D., Mullersman, J., Witte, M., Krishnan, K., and Krolewski, J. (1994). Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase. Mol. Cell. Biol. 14, 8133-8142.
11. Domanski, P., Fish, E., Nadeau, O.W., Witte, M., Platanias, L.C., Yan, H., Krolewski, J., Pitha, P., and Colamonici, O.R. (1997). A region of the beta subunit of the interferon alpha receptor different from box 1 interacts with Jak1 and is sufficient to activate the Jak-Stat pathway and induce an antiviral state. J. Biol. Chem. 272, 26388-26393.
12. Uddin, S., Chamdin, A., and Platanias, L.C. (1995). Interaction of the transcriptional activator Stat-2 with the type I interferon receptor. J. Biol. Chem. 270, 24627-24630.
13. Platanias, L.C., and Colamonici, O.R. (1992). Interferon alpha induces rapid tyrosine phosphorylation of the alpha subunit of its receptor. J. Biol. Chem. 267, 24053-24057.
14. Platanias, L.C., Uddin, S., and Colamonici, O.R. (1994). Tyrosine phosphorylation of the alpha and beta subunits of the type I interferon receptor. Interferon-beta selectively induces tyrosine phosphorylation of an alpha subunit-associated protein. J. Biol. Chem. 269, 17761-17764.
15. Abramovich, C., Shulman, L.M., Ratovitski, E., Harroch, S., Tovey, M., Eid, P., and Revel, M. (1994). Differential tyrosine phosphorylation of the IFNAR chain of the type I interferon receptor and of an associated surface protein in response to IFN-alpha and IFN-beta. EMBO J. 13, 5871-5877.
16. Heim, M.H., Kerr, I.M., Stark, G.R., and Darnell, J.E., Jr. (1995). Contribution of STAT SH2 groups to specific interferon signaling by the Jak-STAT pathway. Science 267, 1347-1349.
17. Gutch, M.J., Daly, C., and Reich, N.C. (1992). Tyrosine phosphorylation is required for activation of an alpha interferon-stimulated transcription factor. Proc. Natl. Acad. Sci. USA 89, 11411-11415.
18. Schindler, C., Shuai, K., Prezioso, V.R., and Darnell, J.E., Jr. (1992). Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257, 809-813.
19. Darnell, J.E., Jr. (1997). STATs and gene regulation. Science 277, 1630-1635.
20. Decker, T., and Kovarik, P. (2000). Serine phosphorylation of STATs. Oncogene 19, 2628-2637.
21. Uddin, S., Sassano, A., Deb, D.K., Verma, A., Majchrzak, B., Rahman, A., Malik, A.B., Fish, E.N., and Platanias, L.C. (2002). Protein kinase C delta (PKCdelta) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J. Biol. Chem. 277, 14408-14416.
22. Fu, X.Y., Kessler, D.S., Veals, S.A., Levy, D.E., and Darnell, J.E., Jr. (1990). ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains. Proc. Natl. Acad. Sci. USA 87, 8555-8559.
23. Li, X., Leung, S., Qureshi, S., Darnell, J.E., Jr., and Stark, G.R. (1996). Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha. J. Biol. Chem. 271, 5790-5794.
24. Ghislain, J.J., Wong, T., Nguyen, M., and Fish, E.N. (2001). The interferon-inducible Stat2:Stat1 heterodimer preferentially binds in vitro to a consensus element found in the promoters of a subset of interferon-stimulated genes. J. Interferon Cytokine Res. 21, 379-388.
25. Gupta, S., Jiang, M., and Pernis, A.B. (1999). IFN-alpha activates Stat6 and leads to the formation of Stat2:Stat6 complexes in B cells. J. Immunol. 163, 3834-3841.
26. Uddin, S., Majchrzak, B., Woodson, J., Arunkumar, P., Alsayed, Y., Pine, R., Young, P.R., Fish, E.N., and Platanias, L.C. (1999). Activation of the p38 mitogen-activated protein kinase by type I interferons. J. Biol. Chem. 274, 30127-30131.
27. Uddin, S., Lekmine, F., Sharma, N., Majchrzak, B., Mayer, I., Young, P.R., Bokoch, G.M., Fish, E.N., and Platanias, L.C. (2000). The Rac1/p38 mitogen-activated protein kinase pathway is required for interferon alpha-dependent transcriptional activation but not serine phosphorylation of Stat proteins. J. Biol. Chem. 275, 27634-27640.
28. Sen, G.C. (2001). Viruses and interferons. Annu. Rev. Microbiol. 55, 255-281.
29. Deonarain, R., Alcami, A., Alexiou, M., Dallman, M.J., Gewert, D.R., and Porter, A.C. (2000). Impaired antiviral response and alpha/beta interferon induction in mice lacking beta interferon. J. Virol. 74, 3404-3409.
30. Van den Broek, M.F., Muller, U., Huang, S., Aguet, M., and Zinkernagel, R.M. (1995). Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J. Virol. 69, 4792-4796.
31. Uddin, S., Yenush, L., Sun, X.J., Sweet, M.E., White, M.F., and Platanias, L.C. (1995). Interferon-alpha engages the insulin receptor substrate-1 to associate with the phosphatidylinositol 3′-kinase. J. Biol. Chem. 270, 15938-15941.
32. Platanias, L.C., Uddin, S., Yetter, A., Sun, X.J., and White, M.F. (1996). The type I interferon receptor mediates tyrosine phosphorylation of insulin receptor substrate 2. J. Biol. Chem. 271, 278-282.
33. Uddin, S., Fish, E.N., Sher, D.A., Gardziola, C., White, M.F., and Platanias, L.C. (1997). Activation of the phosphatidylinositol 3-kinase serine kinase by IFN-alpha. J. Immunol. 158, 2390-2397.
34. Prejean, C., Sarma, T., Kurnasov, O., Usacheva, A., Hemmings, B., Cantley, L., Fruman, D.A., Morrison, L.A., Buller, R.M., and Colamonici, O.R. (2001). Phosphatidylinositol 3-kinase confers resistance to encephalomyocarditis and herpes simplex virus-induced cell death through the activation of distinct downstream effectors. J. Immunol. 167, 4553-4559.
35. Khabar, K.S., Dhalla, M., Siddiqui, Y., Zhou, A., Al-Ahdal, M.N., Der, S.D., Silverman, R.H., and Williams, B.R. (2000). Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes. J. Interferon Cytokine Res. 20, 653-659.
36. Clemens, M.J., and Elia, A. (1997). The double-stranded RNA-dependent protein kinase PKR: structure and function. J. Interferon Cytokine Res. 17, 503-524.
37. Katze, M.G., Wambach, M., Wong, M.L., Garfinkel, M., Meurs, E., Chong, K., Williams, B.R., Hovanessian, A.G., and Barber, G.N. (1991). Functional expression and RNA binding analysis of the interferon-induced, double-stranded RNA-activated, 68,000-Mr protein kinase in a cell-free system. Mol. Cell. Biol. 11, 5497-5505.
38. Meurs, E.F., Watanabe, Y., Kadereit, S., Barber, G.N., Katze, M.G., Chong, K., Williams, B.R., and Hovanessian, A.G. (1992). Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth. J. Virol. 66, 5804-5814.
39. Yang, Y.L., Reis, L.F., Pavlovic, J., Aguzzi, A., Schafer, R., Kumar, A., Williams, B.R., Aguet, M., and Weissmann, C. (1995). Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14, 6095-6106.
40. Balachandran, S., Roberts, P.C., Brown, L.E., Truong, H., Pattnaik, A.K., Archer, D.R., and Barber, G.N. (2000). Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13, 129-141.
41. Stojdl, D.F., Abraham, N., Knowles, S., Marius, R., Brasey, A., Lichty, B.D., Brown, E.G., Sonenberg, N., and Bell, J.C. (2000). The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus. J. Virol. 74, 9580-9585.
42. Abraham, N., Stojdl, D.F., Duncan, P.I., Methot, N., Ishii, T., Dube, M., Vanderhyden, B.C., Atkins, H.L., Gray, D.A., McBurney, M.W., Koromilas, A.E., Brown, E.G., Sonenberg, N., and Bell, J.C. (1999). Characterization of transgenic mice with targeted disruption of the catalytic domain of the double-stranded RNA-dependent protein kinase, PKR. J. Biol. Chem. 274, 5953-5962.
43. Chu, W.M., Ostertag, D., Li, Z.W., Chang, L., Chen, Y., Hu, Y., Williams, B., Perrault, J., and Karin, M. (1999). JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity 11, 721-731.
44. Zamanian-Daryoush, M., Mogensen, T.H., Didonato, J.A., and Williams, B.R. (2000). NF-kappaB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-kappaB-inducing kinase and IkappaB kinase. Mol. Cell. Biol. 20, 1278-1290.
45. Goodbourn, S., Didcock, L., and Randall, R.E. (2000). Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81, 2341-2364.
46. Williams, B.R. (1999). PKR: a sentinel kinase for cellular stress. Oncogene 18, 6112-6120.
47. Balachandran, S., Kim, C.N., Yeh, W.C., Mak, T.W., Bhalla, K., and Barber, G.N. (1998). Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J. 17, 6888-6902.
48. Balachandran, S., Roberts, P.C., Kipperman, T., Bhalla, K.N., Compans, R.W., Archer, D.R., and Barber, G.N. (2000). Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/caspase-8 death signaling pathway. J. Virol. 74, 1513-1523.
49. Donze, O., Dostie, J., and Sonenberg, N. (1999). Regulatable expression of the interferon-induced double-stranded RNA-dependent protein kinase PKR induces apoptosis and fas receptor expression. Virology 256, 322-329.
50. Gil, J., and Esteban, M. (2000). Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): mechanism of action. Apoptosis 5, 107-114.
51. Goh, K.C., Deveer, M.J., and Williams, B.R. (2000). The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin. EMBO J. 19, 4292-4297.
52. Rebouillat, D., and Hovanessian, A.G. (1999). The human 2′,5′-oligoadenylate synthetase family: interferon-induced proteins with unique enzymatic properties. J. Interferon Cytokine Res. 19, 295-308.
53. Iordanov, M.S., Paranjape, J.M., Zhou, A., Wong, J., Williams, B.R., Meurs, E.F., Silverman, R.H., and Magun, B.E. (2000). Activation of p38 mitogen-activated protein kinase and c-Jun NH(2)-terminal kinase by double-stranded RNA and encephalomyocarditis virus: involvement of RNase L, protein kinase R, and alternative pathways. Mol. Cell. Biol. 20, 617-627.
54. Hassel, B.A., Zhou, A., Sotomayor, C., Maran, A., and Silverman, R.H. (1993). A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J. 12, 3297-3304.
55. Ghosh, A., Sarkar, S.N., and Sen, G.C. (2000). Cell growth regulatory and antiviral effects of the P69 isozyme of 2-5 (A) synthetase. Virology 266, 319-328.
56. Ghosh, A., Sarkar, S.N., Rowe, T.M., and Sen, G.C. (2001). A specific isozyme of 2′-5′ oligoadenylate synthetase is a dual function proapoptotic protein of the Bcl-2 family. J. Biol. Chem. 276, 25447-25455.
57. Zhou, A., Paranjape, J., Brown, T.L., Nie, H., Naik, S., Dong, B., Chang, A., Trapp, B., Fairchild, R., Colmenares, C., and Silverman, R.H. (1997). Interferon action and apoptosis are defective in mice devoid of 2′,5′-oligoadenylate-dependent RNase L. EMBO J. 16, 6355-6363.
58. Castelli, J.C., Hassel, B.A., Maran, A., Paranjape, J., Hewitt, J.A., Li, X.L., Hsu, Y.T., Silverman, R.H., and Youle, R.J. (1998). The role of 2′-5′ oligoadenylate-activated ribonuclease L in apoptosis. Cell Death Differ. 5, 313-320.
59. Lee, S.H., and Vidal, S.M. (2002). Functional diversity of Mx proteins: variations on a theme of host resistance to infection. Genome Res. 12, 527-530.
60. Kochs, G., Haener, M., Aebi, U., and Haller, O. (2002). Self-assembly of human MxA GTPase into highly-ordered dynamin-like oligomers. J. Biol. Chem. 277, 14172-14176.
61. Pavlovic, J., Zurcher, T., Haller, O., and Staeheli, P. (1990). Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein. J. Virol. 64, 3370-3375.
62. Frese, M., Kochs, G., Meier-Dieter, U., Siebler, J., and Haller, O. (1995). Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus. J. Virol. 69, 3904-3909.
63. Pavlovic, J., Arzet, H.A., Hefti, H.P., Frese, M., Rost, D., Ernst, B., Kolb, E., Staeheli, P., and Haller, O. (1995). Enhanced virus resistance of transgenic mice expressing the human MxA protein. J. Virol. 69, 4506-4510.
64. Schwemmle, M., Weining, K.C., Richter, M.F., Schumacher, B., and Staeheli, P. (1995). Vesicular stomatitis virus transcription inhibited by purified MxA protein. Virology 206, 545-554.
65. Frese, M., Kochs, G., Feldmann, H., Hertkorn, C., and Haller, O. (1996). Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J. Virol. 70, 915-923.
66. Landis, H., Simon-Jodicke, A., Kloti, A., Di Paolo, C., Schnorr, J.J., Schneider-Schaulies, S., Hefti, H.P., and Pavlovic, J. (1998). Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins. J. Virol. 72, 1516-1522.
67. Chieux, V., Chehadeh, W., Harvey, J., Haller, O., Wattre, P., and Hober, D. (2001). Inhibition of Coxsackievirus B4 replication in stably transfected cells expressing human MxA protein. Virology 283, 84-92.
68. Schneider-Schaulies, S., Schneider-Schaulies, J., Schuster, A., Bayer, M., Pavlovic, J., and Ter Meulen, V. (1994). Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells. J. Virol. 68, 6910-6917.
69. Gordien, E., Rosmorduc, O., Peltekian, C., Garreau, F., Brechot, C., and Kremsdorf, D. (2001). Inhibition of hepatitis B virus replication by the interferon-inducibl e MxA protein. J. Virol. 75, 2684-2691.
70. Zhou, A., Paranjape, J.M., Der, S.D., Williams, B.R., and Silverman, R.H. (1999). Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology 258, 435-440.
71. Miettinen, M., Sareneva, T., Julkunen, I., and Matikainen, S. (2001). IFNs activate toll-like receptor gene expression in viral infections. Genes Immun. 2, 349-355.
72. Sato, K., Hida, S., Takayanagi, H., Yokochi, T., Kayagaki, N., Takeda, K., Yagita, H., Okumura, K., Tanaka, N., Taniguchi, T., and Ogasawara, K. (2001). Antiviral response by natural killer cells through TRAIL gene induction by IFNalpha/beta. Eur. J. Immunol. 31, 3138-3146.
73. Chin, K.C., and Cresswell, P. (2001). Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc. Natl. Acad. Sci. USA 98, 15125-15130.
74. Akira, S., Takeda, K., and Kaisho, T. (2001). Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2, 675-680.
75. Akira, S. (2001). Toll-like receptors and innate immunity. Adv. Immunol. 78, 1-56.
76. Alexopoulou, L., Holt, A.C., Medzhitov, R., and Flavell, R.A. (2001). Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor-3. Nature 413, 732-738.
77. Krug, A., Towarowski, A., Britsch, S., Rothenfusser, S., Hornung, V., Bals, R., Giese, T., Engelmann, H., Endres, S., Krieg, A.M., and Hartmann, G. (2001). Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 31, 3026-3037.
78. Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., and Akira, S. (2002). Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3, 196-200.
79. Toshchakov, V., Jones, B.W., Perera, P.Y., Thomas, K., Cody, M.J., Zhang, S., Williams, B.R., Major, J., Hamilton, T.A., Fenton, M.J., and Vogel, S.N. (2002). TLR4, but not TLR2, mediates IFN-beta-induced STAT1-alpha/beta-dependent gene expression in macrophages. Nat. Immunol. 3, 392-398.
80. Gamero, A.M., and Larner, A.C. (2001). Vanadate facilitates interferon alpha-mediated apoptosis that is dependent on the Jak/Stat pathway. J. Biol. Chem. 276, 13547-13553.
81. Manna, S.K., Mukhopadhyay, A., and Aggarwal, B.B. (2000). IFN-alpha suppresses activation of nuclear transcription factors NF-kappa B and activator protein 1 and potentiates TNF-induced apoptosis. J. Immunol. 165, 4927-4934.
82. Thyrell, L., Erickson, S., Zhivotovsky, B., Pokrovskaja, K., Sangfelt, O., Castro, J., Einhorn, S., and Grander, D. (2002). Mechanisms of interferon-alpha induced apoptosis in malignant cells. Oncogene 21, 1251-1262.
83. 1 arrest. Nature 313, 597-600.
84. Iwase, S., Furukawa, Y., Kikuchi, J., Nagai, M., Terui, Y., Nakamura, M., and Yamada, H. (1997). Modulation of E2F activity is linked to interferon-induced growth suppression of hematopoietic cells. J. Biol. Chem. 272, 12406-12414.
85. Sangfelt, O., Erickson, S., and Grander, D. (2000). Mechanisms of interferon-induced cell cycle arrest. Front. Biosci. 5, D479-487.
86. 1 Cdk-complexes and activation of pocket proteins. Oncogene 18, 2798-2810.
87. Thomas, N.S., Pizzey, A.R., Tiwari, S., Williams, C.D., and Yang, J. (1998). p130, p107, and pRb are differentially regulated in proliferating cells and during cell cycle arrest by alphainterferon. J. Biol. Chem. 273, 23659-23667.
88. Furukawa, Y., Iwase, S., Kikuchi, J., Nakamura, M., Yamada, H., and Matsuda, M. (1999). Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes. Oncogene 18, 2003-2014.
89. Kimchi, A. (1992). Cytokine triggered molecular pathways that control cell cycle arrest. J. Cell. Biochem. 50, 1-9.
90. Landolfo, S., Gariglio, M., Gribaudo, G., and Lemdo, D. (1998). The Ifi 200 genes: an emerging family of IFN-inducible genes. Biochimie 80, 721-728.
91. Gutterman, J.U., and Choubey, D. (1999). Retardation of cell proliferation after expression of p202 accompanies an increase in p21 (WAF1/CIP1). Cell Growth Differ. 10, 93-100.
92. Geng, Y., and Choubey, D. (2000). Differential induction of the 200-family proteins in Daudi Burkitt's lymphoma cells by interferon-alpha. J. Biol. Regul. Homeost. Agents 14, 263-268.
93. Johnstone, R.W., Kerry, J.A., and Trapani, J.A. (1998). The human interferon-inducible protein, IFI 16, is a repressor of transcription. J. Biol. Chem. 273, 17172-17177.
94. Choubey, D., and Lengyel, P. (1995). Binding of an interferon-inducible protein (p202) to the retinoblastoma protein. J. Biol. Chem. 270, 6134-6140.
95. Choubey, D., and Gutterman, J.U. (1997). Inhibition of E2F-4/DP-1-stimulated transcription by p202. Oncogene 15, 291-301.
96. Hertel, L., Rolle, S., De Andrea, M., Azzimonti, B., Osello, R., Gribaudo, G., Gariglio, M., and Landolfo, S. (2000). The retinoblastoma protein is an essential mediator that links the interferon-inducible 204 gene to cell-cycle regulation. Oncogene 19, 3598-3608.
97. Feller, S.M. (2001). Crk family adaptors-signalling complex formation and biological roles. Oncogene 20, 6348-6371.
98. Gotoh, T., Hattori, S., Nakamura, S., Kitayama, H., Noda, M., Takai, Y., Kaibuchi, K., Matsui, H., Hatase, O., Takahashi, H., et al. (1995). Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G. Mol. Cell. Biol. 15, 6746-6753.
99. Ahmad, S., Alsayed, Y.M., Druker, B.J., and Platanias, L.C. (1997). The type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein. J. Biol. Chem. 272, 29991-29994.
100. Fish, E.N., Uddin, S., Korkmaz, M., Majchrzak, B., Druker, B.J., and Platanias, L.C. (1999). Activation of a CrkL-Stat5 signaling complex by type I interferons. J. Biol. Chem. 274, 571-573.
101. Lekmine, F., Sassano, A., Uddin, S., Majchrzak, B., Miura, O., Druker, B.J., Fish, E.N., Imamoto, A., and Platanias, L.C. (2002). The CrkL adapter protein is required for type I interferon-dependent gene transcription and activation of the small G-protein Rap1. Biochem. Biophys. Res. Commun. 291, 744-750.
102. Platanias, L.C., Uddin, S., Bruno, E., Korkmaz, M., Ahmad, S., Alsayed, Y., Van den Berg, D., Druker, B.J., Wickrema, A., and Hoffman, R. (1999). CrkL and CrkII participate in the generation of the growth inhibitory effects of interferons on primary hematopoietic progenitors. Exp. Hematol. 27, 1315-1321.
103. Grumbach, I.M., Mayer, I.A., Uddin, S., Lekmine, F., Majchrzak, B., Yamauchi, H., Fujita, S., Druker, B., Fish, E.N., and Platanias, L.C. (2001). Engagement of the CrkL adaptor in interferon alpha signalling in BCR-ABL-expressing cells. Br. J. Haematol. 112, 327-336.
104. Mayer, I.A., Verma, A., Grumbach, I.M., Uddin, S., Lekmine, F., Ravandi, F., Majchrzak, B., Fujita, S., Fish, E.N., and Platanias, L.C. (2001). The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cells. J. Biol. Chem. 276, 28570-28577.
105. Verma, A., Deb, D.K., Sassano, A., Uddin, S., Varga, J., Wickrema, A., and Platanias, L.C. (2002). Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis. J. Biol. Chem. 277, 7726-7735.
106. Platanias, L.C., and Sweet, M.E. (1994). Interferon alpha induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells. J. Biol. Chem. 269, 3143-3146.
107. Micouin, A., Wietzerbin, J., Steunou, V., and Martyre, M.C. (2000). p94(vav) associates with the type I interferon (IFN) receptor and contributes to the antiproliferative effect of IFN-alpha in megakaryocytic cell lines. Oncogene 19, 387-394.
108. Adam, L., Bandyopadhyay, D., and Kumar, P. (2000). Interferon-alpha signaling promotes nucleus-to-cytoplasmic redistribution of p95Vav, and formation of a multisubunit complex involving Vav, Ku80, and Tyk2. Biochem. Biophys. Res. Commun. 267, 692-696.
109. Crespo, P., Bustelo, X.R., Aaronson, D.S., Coso, O.A., Lopez-Barahona, M., Barbacid, M., and Gutkind, J.S. (1996). Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav. Oncogene 13, 455-460.
110. Crespo, P., Schuebel, K.E., Ostrom, A.A., Gutkind, J.S., and Bustelo, X.R. (1997). Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 385, 169-172.
111. Lanzavecchia, A., and Sallusto, F. (2001). Antigen decoding by T lymphocytes: from synapses to fate determination. Nat. Immunol. 2, 487-492.
112. Myers, M.G., Jr., Sun, X.J., and White, M.F. (1994). The IRS-1 signaling system. Trends Biochem. Sci. 19, 289-293.
113. White, M.F., and Kahn, C.R. (1994). The insulin signaling system. J. Biol. Chem. 269, 1-4.
114. White, M.F. (1998). The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Recent Prog. Horm. Res. 53, 119-138.
115. Guidotti, L.G., and Chisari, F.V. (2001). Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19, 65-91.
116. Biron, C.A. (2001). Interferons alpha and beta as immune regulators - a new look. Immunity 14, 661-664.
117. Cremer, I., Ghysdael, J., and Vieillard, V. (2002). A non-classical ISRE/ISGF3 pathway mediates induction of RANTES gene transcription by type I IFNs. FEBS Lett. 511, 41-45.
118. Zang, Y.C., Halder, J.B., Samanta, A.K., Hong, J., Rivera, V.M., and Zhang, J.Z. (2001). Regulation of chemokine receptor CCR5 and production of RANTES and MIP- 1alpha by interferon-beta. J. Neuroimmunol. 112, 174-180.
119. Biron, C.A., Nguyen, K.B., Pien, G.C., Cousens, L.P., and Salazar-Mather, T.P. (1999). Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17, 189-220.
120. Luft, T., Pang, K.C., Thomas, E., Hertzog, P., Hart, D.N., Trapani, J., and Cebon, J. (1998). Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161, 1947-1953.
121. Parronchi, P., De Carli, M., Manetti, R., Simonelli, C., Sampognaro, S., Piccinni, M.P., Macchia, D., Maggi, E., Del Prete, G., and Romagnani, S. (1992). IL- 4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J. Immunol. 149, 2977-2983.
122. + T cells. J. Exp. Med. 178, 1655-1663.
123. Marrack, P., Kappler, J., and Mitchell, T. (1999). Type I interferons keep activated T cells alive. J. Exp. Med. 189, 521-530.
124. Van Uden, J.H., Tran, C.H., Carson, D.A., and Raz, E. (2001). Type I interferon is required to mount an adaptive response to immunostimulatory DNA. Eur. J. Immunol. 31, 3281-3290.
125. Lin, Q., Dong, C., and Cooper, M.D. (1998). Impairment of T and B cell development by treatment with a type I interferon. J. Exp. Med. 187, 79-87.
126. Ruuth, K., Carlsson, L., Hallberg, B., and Lundgren, E. (2001). Interferon-alpha promotes survival of human primary B-lymphocytes via phosphatidylinositol 3-kinase. Biochem. Biophys. Res. Commun. 284, 583-586.
127. De Veer, M.J., Holko, M., Frevel, M., Walker, E., Der, S., Paranjape, J.M., Silverman, R.H., and Williams, B.R. (2001). Functional classification of interferon-stimulated genes identified using microarrays. J. Leukocyte Biol. 69, 912-920.
128. Croze, E., Russell-Harde, D., Wagner, T.C., Pu, H., Pfeffer, L.M., and Perez, H.D. (1996). The human type I interferon receptor. Identification of the interferon beta-specific receptor-associated phosphoprotein. J. Biol. Chem. 271, 33165-33168.
129. Domanski, P., Nadeau, O.W., Platanias, L.C., Fish, E., Kellum, M., Pitha, P., and Colamonici, O.R. (1998). Differential use of the betaL subunit of the type I interferon (IFN) receptor determines signaling specificity for IFNalpha2 and IFNbeta. J. Biol. Chem. 273, 3144-3147.
130. Rani, M.R., Foster, G.R., Leung, S., Leaman, D., Stark, G.R., and Ransohoff, R.M. (1996). Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha. J. Biol. Chem. 271, 22878-22884.
131. Da Silva, A.J., Brickelmaier, M., Majeau, G.R., Lukashin, A.V., Peyman, J., Whitty, A., and Hochman, P.S. (2002). Comparison of gene expression patterns induced by treatment of human umbilical vein endothelial cells with IFN-α2b vs. IFN-β1a: understanding the functional relationship between distinct type I interferons that act through a common receptor. J. Interferon Cytokine Res. 22, 173-188.